Targeting FcRn for immunomodulation: benefits, risks, and practical considerations / Hans-Hartmut Peter, Hans D. Ochs, Charlotte Cunningham-Rundles, Donald C. Vinh, Peter Kiessling, Bernhard Greve, Stephen Jolles
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
Amsterdam u.a.: Elsevier ; 2020 Freiburg: Albert-Ludwigs-Universität Freiburg ; 2020 |
| Enthalten in: |
The journal of allergy and clinical immunology - 146, 3 (2020), 479-491.e5 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Peter, Hans-Hartmut, 1942- [VerfasserIn] |
|---|
| Links: |
nbn-resolving.de [kostenfrei] |
|---|
| Themen: |
|---|
| Umfang: |
1 Online-Ressource (18 Seiten) ; Illustration |
|---|
| doi: |
10.1016/j.jaci.2020.07.016 |
|---|---|
| Weitere IDs: |
urn:nbn:de:bsz:25-freidok-1678750 FRUB-opus-167875 |
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1743047584 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 1743047584 | ||
| 003 | DE-627 | ||
| 005 | 20230427191016.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201216s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a urn:nbn:de:bsz:25-freidok-1678750 |2 urn | |
| 024 | 7 | |a 10.1016/j.jaci.2020.07.016 |2 doi | |
| 024 | 8 | |a FRUB-opus-167875 |q Opus Nr. | |
| 035 | |a (DE-627)1743047584 | ||
| 035 | |a (DE-599)KXP1743047584 | ||
| 035 | |a (OCoLC)1227264106 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DE-101 |
| 100 | 1 | |a Peter, Hans-Hartmut |d 1942- |e verfasserin |0 (DE-588)106968971 |0 (DE-627)593634217 |0 (DE-576)304097586 |4 aut | |
| 245 | 1 | 0 | |a Targeting FcRn for immunomodulation: benefits, risks, and practical considerations |c Hans-Hartmut Peter, Hans D. Ochs, Charlotte Cunningham-Rundles, Donald C. Vinh, Peter Kiessling, Bernhard Greve, Stephen Jolles |
| 264 | 1 | |a Amsterdam [u.a.] |b Elsevier |c 2020 | |
| 264 | 2 | |a Freiburg |b Albert-Ludwigs-Universität Freiburg |c 2020 | |
| 300 | |a 1 Online-Ressource (18 Seiten) |b Illustration | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 650 | 0 | 7 | |0 (DE-588)4026626-6 |0 (DE-627)106287516 |0 (DE-576)208967338 |a Immunglobuline |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4001090-9 |0 (DE-627)10639861X |0 (DE-576)208841091 |a Albumine |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4197887-0 |0 (DE-627)10519297X |0 (DE-576)216832667 |a Antikörpermangelsyndrom |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4215429-7 |0 (DE-627)105057266 |0 (DE-576)210225629 |a Autoantikörper |2 gnd |
| 700 | 1 | |a Ochs, Hans D. |d 1936- |e verfasserin |0 (DE-588)141961775 |0 (DE-627)704106973 |0 (DE-576)327082151 |4 aut | |
| 700 | 1 | |a Cunningham-Rundles, Charlotte |e verfasserin |4 aut | |
| 700 | 1 | |a Vinh, Donald C. |e verfasserin |4 aut | |
| 700 | 1 | |a Kiessling, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Greve, Bernhard |e verfasserin |4 aut | |
| 700 | 1 | |a Jolles, Stephen |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Sonderdruck aus |t The journal of allergy and clinical immunology |g 146, 3 (2020), 479-491.e5 |x 0091-6749 |
| 856 | 4 | 0 | |u https://nbn-resolving.de/urn:nbn:de:bsz:25-freidok-1678750 |q application/pdf |x Resolving-System |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jaci.2020.07.016 |x Resolving-System |z kostenfrei |
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a ISIL_DE-25 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_2403 | ||
| 912 | |a ISIL_DE-LFER | ||
| 935 | |c so | ||
| 951 | |a BO | ||
| 980 | |2 2003 |1 01 |x DE-25 |b 3826256948 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |k Elektronischer Volltext - Zugang über WWW |y l01 |z 16-12-20 | ||
| 980 | |2 2403 |1 01 |x DE-LFER |b 3832533249 |c 00 |f --%%-- |d --%%-- |e n |j --%%-- |y l01 |z 08-01-21 | ||
| 981 | |2 2003 |1 01 |x DE-25 |r http://nbn-resolving.de/urn:nbn:de:bsz:25-freidok-1678750 | ||
| 981 | |2 2403 |1 01 |x DE-LFER |r https://doi.org/10.1016/j.jaci.2020.07.016 | ||
| 981 | |2 2403 |1 01 |x DE-LFER |r https://nbn-resolving.de/urn:nbn:de:bsz:25-freidok-1678750 | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 00 |s s |a FcRn | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 01 |s s |a Neonatal | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 02 |s s |a Fc receptor | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 03 |s s |a IgG | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 04 |s s |a Antibody-mediated autoimmunity | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 05 |s s |a FcRn inhibitors | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 06 |s s |a Infection risk | ||